Skip to main content
. 2005 Oct 4;93(8):953–959. doi: 10.1038/sj.bjc.6602806

Table 4. Cox-2 haplotypes and risk for advanced colorectal adenomas in association with tobacco usage.

Haplotype Never smoker
Current smoker
Former smoker
Intron 5-5229 and &3′UTR-8494 Cases/controls OR 95% CI Cases/controls OR 95% CI Cases/controls OR 95% CI
All
 TT 377/458   142/63 3.12 (2.24, 4.36) 440/485 1.13 (0.93, 1.38)
 TC 111/109 1.24 (0.92, 1.68) 42/16 3.71 (2.03, 6.77) 145/122 1.50 (1.13, 1.99)
 GC 89/124 0.86 (0.63, 1.17) 25/18 1.83 (0.97, 3.45) 120/111 1.33 (0.99, 1.79)
             
Males
 TT 228/274   97/49 2.81 (1.89, 4.18) 351/371 1.20 (0.95, 1.52)
 TC 76/64 1.41 (0.96, 2.07) 28/11 3.76 (1.80, 7.83) 113/90 1.64 (1.17, 2.29)
 GC 47/73 0.74 (0.49, 1.12) 15/13 1.38 (0.63, 3.01) 88/88 1.28 (0.90, 1.82)
             
Females
 TT 149/184   45/14 4.45 (2.32, 8.51) 89/114 1.00 (0.70, 1.43)
 TC 35/45 0.99 (0.60, 1.64) 14/5 3.82 (1.32, 11.0) 32/32 1.25 (0.72, 2.15)
 GC 42/51 1.05 (0.65, 1.68) 10/5 3.10 (1.01, 9.48) 32/23 1.73 (0.96, 3.12)

OR=odds ratio; CI=confidence interval. Adjusted for age and NSAIDs usage.